Home › Research › Digital health tools
Proteomic signature of dementia risk in type 2 diabetes
Zhibo Wang, Yuye Ning, Pei‐Yang Gao, Lingzhi Xu, Shuman Cao, Yan Li, Jianping Jia. Journal of Advanced Research, 2025-08-18
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
We identified 471 proteins with significant interaction effects between T2D and dementia risk. In non-T2D individuals, elevated levels of neuronal pentraxin receptor (NPTXR, HR = 0.74, 95 %CI:0.66-0.83) and carbonic anhydrase 14 (CA14, HR = 0.67, 95 %CI:0.60-0.75) were exclusively associated with decreased dementia risk. Conversely, in T2D patients, elevated rho guanine nucleotide exchange factor 12 (ARHGEF12, HR = 1.45, 95 %CI:1.10-1.91) was specifically associated with increased dementia risk. A 51-protein model accurately predicted 15-year dementia risk in T2D patients (AUC = 0.835, C-index = 0.829), outperforming conventional clinical risk scores and maintaining high accuracy for Alzheimer's disease and vascular dementia. Pathway analysis revealed enrichment of IL6-JAK-STAT3 signaling in T2D-related dementia, while dysregulation of fatty acid metabolism was specific to T2D-associated Alzheimer's disease. This large-scale proteomic analysis identifies specific molecular signatures that differentiate dementia risk in diabetic and non-diabetic populations, with potential applications for early risk stratification and targeted interventions. The identified pathways provide novel insights into the pathophysiological processes connecting T2D and dementia and suggest potential therapeutic targets.
What this study adds
Evidence grade: Low
The record lists 2,920 participants. This large-scale proteomic analysis identified 471 proteins with significant interaction effects between type 2 diabetes and dementia risk, and a 51-protein model predicted 15-year dementia risk in people with type 2 diabetes with an AUC of 0.835. Reported effect size: HR = 0.74; HR = 0.67; HR = 1.45.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wang, Z., Ning, Y., Gao, P., Xu, L., Cao, S., Li, Y., et al. (2025). Proteomic signature of dementia risk in type 2 diabetes. Journal of Advanced Research. https://doi.org/10.1016/j.jare.2025.08.012
Vancouver
Wang Z, Ning Y, Gao P, Xu L, Cao S, Li Y, et al. Proteomic signature of dementia risk in type 2 diabetes. Journal of Advanced Research. 2025. doi:10.1016/j.jare.2025.08.012. PMID: 40829688.
BibTeX
@article{wang2025-40829688,
author = {Wang, Zhibo and Ning, Yuye and Gao, Pei‐Yang and Xu, Lingzhi and Cao, Shuman and Li, Yan and Jia, Jianping},
title = {{Proteomic signature of dementia risk in type 2 diabetes}},
journal = {Journal of Advanced Research},
year = {2025},
doi = {10.1016/j.jare.2025.08.012},
pmid = {40829688},
url = {https://doi.org/10.1016/j.jare.2025.08.012}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- We identified 471 proteins with significant interaction effects between T2D and dementia risk.
- In non-T2D individuals, elevated levels of neuronal pentraxin receptor (NPTXR, HR = 0.74, 95 %CI:0.66-0.83) and carbonic anhydrase 14 (CA14, HR = 0.67, 95 %CI:0.60-0.75) were exclusively associated with decreased dementia risk.
- Conversely, in T2D patients, elevated rho guanine nucleotide exchange factor 12 (ARHGEF12, HR = 1.45, 95 %CI:1.10-1.91) was specifically associated with increased dementia risk.
- A 51-protein model accurately predicted 15-year dementia risk in T2D patients (AUC = 0.835, C-index = 0.829), outperforming conventional clinical risk scores and maintaining high accuracy for Alzheimer's disease and vascular dementia.
- Pathway analysis revealed enrichment of IL6-JAK-STAT3 signaling in T2D-related dementia, while dysregulation of fatty acid metabolism was specific to T2D-associated Alzheimer's disease.
Why it matters
This large-scale proteomic analysis identified 471 proteins with significant interaction effects between type 2 diabetes and dementia risk, and a 51-protein model predicted 15-year dementia risk in people with type 2 diabetes with an AUC of 0.835. The authors say the identified pathways suggest potential therapeutic targets, but this is a risk-stratification and target-identification study, not a tested treatment or cure.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Participants2,920
- Effect sizeHR = 0.74; HR = 0.67; HR = 1.45
- Evidence strengthLow
How this study scored 50/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Advanced Research) |
| Journal's citation record | 1 / 4 | Journal of Advanced Research: journal h-index 142 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 3 / 4 | 2,920 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 6 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 3.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Jianping Jia: h-index 61 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Chinese Academy of Medical Sciences & Peking Union Medical College: institution h-index 950 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40829688) |
| Free to read | 2 / 2 | Free to read |
| Total | 50 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.jare.2025.08.012
- PubMed: 40829688
- Original source →
- Free full text: Journal of Advanced Research →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Digital health tools from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.